This is different from semaglutide, which works mainly through GLP-1, and tirzepatide, which works through GLP-1 and GIP
Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
At a roundtable held on October 9 by the Alliance for Pharmacy Compounding, four pharmacists said they were still having trouble filling name-brand tirzepatide prescriptions
Others experience feeling unusually cold , likely related to reduced caloric intake and metabolic changes
Many report a reduction in appetite within a few weeks of starting glp 1
When your prescription says 0.25mg, 0.5mg, or 1mg, it describes how much semaglutide peptide enters your body